763 related articles for article (PubMed ID: 31009106)
1. The expression of long non coding RNA genes is associated with expression with polymorphisms of HULC rs7763881 and MALAT1 rs619586 in hepatocellular carcinoma and HBV Egyptian patients.
Motawi TMK; El-Maraghy SA; Sabry D; Mehana NA
J Cell Biochem; 2019 Sep; 120(9):14645-14656. PubMed ID: 31009106
[TBL] [Abstract][Full Text] [Related]
2. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV.
Lu J; Xie F; Geng L; Shen W; Sui C; Yang J
Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706
[TBL] [Abstract][Full Text] [Related]
3. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population.
Liu Y; Pan S; Liu L; Zhai X; Liu J; Wen J; Zhang Y; Chen J; Shen H; Hu Z
PLoS One; 2012; 7(4):e35145. PubMed ID: 22493738
[TBL] [Abstract][Full Text] [Related]
4. Genetic polymorphisms in the miR-372 (rs12983273) and LncRNA HULC (rs7763881) genes and susceptibility to Hepatitis B virus (HBV) infection.
Shahen SM; Elshenawy SZ; Mohamed SE; Talaat RM
Mol Biol Rep; 2021 Dec; 48(12):7901-7906. PubMed ID: 34677712
[TBL] [Abstract][Full Text] [Related]
5. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.
Xie H; Ma H; Zhou D
Biomed Res Int; 2013; 2013():136106. PubMed ID: 23762823
[TBL] [Abstract][Full Text] [Related]
6. Association of twelve polymorphisms in three onco-lncRNA genes with hepatocellular cancer risk and prognosis: A case-control study.
Wang BG; Xu Q; Lv Z; Fang XX; Ding HX; Wen J; Yuan Y
World J Gastroenterol; 2018 Jun; 24(23):2482-2490. PubMed ID: 29930469
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Value of Long Non-Coding RNA HULC and MALAT1 Following the Curative Resection of Hepatocellular Carcinoma.
Sonohara F; Inokawa Y; Hayashi M; Yamada S; Sugimoto H; Fujii T; Kodera Y; Nomoto S
Sci Rep; 2017 Nov; 7(1):16142. PubMed ID: 29170515
[TBL] [Abstract][Full Text] [Related]
8. LncRNA H19 promotes the development of hepatitis B related hepatocellular carcinoma through regulating microRNA-22 via EMT pathway.
Li L; Han T; Liu K; Lei CG; Wang ZC; Shi GJ
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5392-5401. PubMed ID: 31298392
[TBL] [Abstract][Full Text] [Related]
9. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q
Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618
[TBL] [Abstract][Full Text] [Related]
10. Association of rs6983267 at 8q24, HULC rs7763881 polymorphisms and serum lncRNAs CCAT2 and HULC with colorectal cancer in Egyptian patients.
Shaker OG; Senousy MA; Elbaz EM
Sci Rep; 2017 Nov; 7(1):16246. PubMed ID: 29176650
[TBL] [Abstract][Full Text] [Related]
11. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
[TBL] [Abstract][Full Text] [Related]
12. Knowledge-based analyses reveal new candidate genes associated with risk of hepatitis B virus related hepatocellular carcinoma.
Jiang D; Deng J; Dong C; Ma X; Xiao Q; Zhou B; Yang C; Wei L; Conran C; Zheng SL; Ng IO; Yu L; Xu J; Sham PC; Qi X; Hou J; Ji Y; Cao G; Li M
BMC Cancer; 2020 May; 20(1):403. PubMed ID: 32393195
[TBL] [Abstract][Full Text] [Related]
13. Association of long noncoding RNA H19 rs2839698 C/T with hepatitis B virus infection and hepatocellular carcinoma risk.
Motawi TK; Mady AE; Elhelbawy M; Talaat RM; Shahin NN
J Biochem Mol Toxicol; 2024 Apr; 38(4):e23673. PubMed ID: 38481010
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic long noncoding RNA MALAT1 and HCV-related hepatocellular carcinoma.
Toraih EA; Ellawindy A; Fala SY; Al Ageeli E; Gouda NS; Fawzy MS; Hosny S
Biomed Pharmacother; 2018 Jun; 102():653-669. PubMed ID: 29604585
[TBL] [Abstract][Full Text] [Related]
15. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive analysis of long non-coding RNA expression profiles in hepatitis B virus-related hepatocellular carcinoma.
Gong X; Wei W; Chen L; Xia Z; Yu C
Oncotarget; 2016 Jul; 7(27):42422-42430. PubMed ID: 27285756
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNAs in hepatitis B virus-related hepatocellular carcinoma.
Yu TT; Xu XM; Hu Y; Deng JJ; Ge W; Han NN; Zhang MX
World J Gastroenterol; 2015 Jun; 21(23):7208-17. PubMed ID: 26109807
[TBL] [Abstract][Full Text] [Related]
18. Nonreceptor protein tyrosine phosphatases (NRPTPs) gene family associates with the risk of hepatocellular carcinoma in a Chinese hepatitis B virus-related subjects.
Shen N; Wang P; Li Y; Zhu Y; Gong Y; Zhong R; Lu Y; Cheng L
Mol Carcinog; 2020 Aug; 59(8):980-988. PubMed ID: 32484301
[TBL] [Abstract][Full Text] [Related]
19. The association of lncRNA-HULC polymorphisms with hepatocellular cancer risk and prognosis.
Wang BG; Lv Z; Ding HX; Fang XX; Wen J; Xu Q; Yuan Y
Gene; 2018 Sep; 670():148-154. PubMed ID: 29803923
[TBL] [Abstract][Full Text] [Related]
20. Genetic Variations in XRCC4 (rs1805377) and ATF6 (rs2070150) are not Associated with Hepatocellular Carcinoma in Thai Patients with Hepatitis B Virus Infection.
Makkoch J; Praianantathavorn K; Sopipong W; Chuaypen N; Tangkijvanich P; Payungporn S
Asian Pac J Cancer Prev; 2016; 17(2):591-5. PubMed ID: 26925648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
